Galmed Acquires Colospan in $4.5M Deal; Shares Decline
Galmed Pharmaceuticals (NASDAQ:GLMD) has agreed to acquire Colospan, a commercial-stage medical device developer focused on colorectal surgery, for $4.5 million. The acquisition will make Colospan a wholly owned subsidiary of Galmed.
Tickers: $GLMD
Topics: M&A Medical Devices